Pitching sessions
Transformative stratups in Next-Gen Diagnostics & Lab Automation
Pitching session summary
Discover the future of biotech as startups push the boundaries of diagnostics, lab automation and analytics. This session will feature groundbreaking technologies transforming disease detection, laboratory sciences and ultimately drug development. Presenters will explore innovations in single-particle dispension, real-time immunoassays, VR-powered diagnostics, next-gen allergy testing, precision medicine driven by biomarker insights and solutions advancing light-dependent biological techniques. Join experts and investors as they explore how these technologies are reshaping the landscape of healthcare and biotech.
Date, time and room information
6 May, 12:15-13:00, room Marriott 3+4+5
Moderation
| Name | Position | Institution |
|---|---|---|
| Samantha Paoletti | Head of Research and BD Life Science Technologies | CSEM |
Pitching companies
| Company name | Pitcher | Title of presentation | Link to company website |
|---|---|---|---|
| OptoLumina | Thomas Höhener, CEO of OptoLumina AG | The Lumiplate – A Multiwell Plate Lighting Device to Illuminate Biotech | https://optolumina.com/ |
| Bioscibex | Chloé Albietz, CEO | Changing the way we make drugs | https://bioscibex.com/ |
| SEED BIOSCIENCES | Maxence Vieux-Rochas | https://seedbiosciences.com/ | |
| Atanis Biotech | Erwan Eriau, COO | Bringing Allergy diagnostics in the era of biotechnology | https://www.atanis-biotech.com/ |
| Elionova | Bruno Oesch, CEO and CSO | One-step Real-time Immunoassays in 10 min: the ElioDX™ technology | https://www.elionova.com/ |
| Xemperia | Sarah Cattin, CTO | A revolution in early breast cancer detection: a blood test to save lives | https://xemperia.com/ |
| MachineMD | Dominic Senn, CEO | Opportunity in AI-Powered Brain Health | https://www.machinemd.com/ |
Jury members
| Name | Position | Institution |
|---|---|---|
| Bernard Spycher | Board Member | SVDI |
| Miro Venturi | President | Diamante Healthcare Consulting Sagl |
| Cédric Barra | Senior Investment Manager Life Sciences | OCCIDENT |
| Steffen Ehrhadt | VP Investor Community, Partnerships and Sustainability | SICTIC |
